Showing results (121-130 of 266) with videos related to

Sort By:
Pageof 27
Frontiers in Nutrition|January 2, 2024
Influence of dietary pattern on anti-tuberculosis treatment outcomes in persons with dysglycemia: a Peruvian prospective cohort studyMaría B Arriaga, Mariana Araújo-Pereira, Vanessa M B Andrade, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 31, 2019
Differential Expression of Activation Markers by Mycobacterium tuberculosis-specific CD4+ T Cell Distinguishes Extrapulmonary From Pulmonary Tuberculosis and Latent InfectionPaulo S Silveira-Mattos, Beatriz Barreto-Duarte, Beatriz Vasconcelos, et al.
The Lancet. Public Health|April 2, 2025
Changes in incarceration and tuberculosis notifications from prisons during the COVID-19 pandemic in Europe and the Americas: a time-series analysis of national surveillance dataAmy Zheng, Lena Faust, Anthony D Harries, et al.
The Journal of Infectious Diseases|November 15, 2019
Lack of Weight Gain During the First 2 Months of Treatment and Human Immunodeficiency Virus Independently Predict Unsuccessful Treatment Outcomes in TuberculosisLauren S Peetluk, Peter F Rebeiro, Marcelo Cordeiro-Santos, et al.
Frontiers in Immunology|July 7, 2018
Lysosomal Cathepsin Release Is Required for NLRP3-Inflammasome Activation by <i>Mycobacterium tuberculosis</i> in Infected MacrophagesEduardo P Amaral, Nicolas Riteau, Mahtab Moayeri, et al.
Malaria Journal|May 13, 2010
Towards a precise test for malaria diagnosis in the Brazilian Amazon: comparison among field microscopy, a rapid diagnostic test, nested PCR, and a computational expert system based on artificial neural networksBruno B Andrade, Antonio Reis-Filho, Austeclino M Barros, et al.
The Journal of Infectious Diseases|January 23, 2024
Prediction Models for Adverse Drug Reactions During Tuberculosis Treatment in BrazilFelipe Ridolfi, Gustavo Amorim, Lauren S Peetluk, et al.
BMJ Global Health|April 22, 2026
Programmatic impact and cost-effectiveness of scaling up the short-course 3HP regimen for tuberculosis preventive treatment in BrazilKlauss Villalva-Serra, Beatriz Barreto-Duarte, Moreno M Rodrigues, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 13, 2005
Saliva from Lutzomyia longipalpis induces CC chemokine ligand 2/monocyte chemoattractant protein-1 expression and macrophage recruitmentClarissa R Teixeira, Maria Jânia Teixeira, Regis B B Gomes, et al.
The Lancet. Microbe|May 11, 2022
Inflammatory profile of patients with tuberculosis with or without HIV-1 co-infection: a prospective cohort study and immunological network analysisElsa Du Bruyn, Kiyoshi F Fukutani, Neesha Rockwood, et al.
Pageof 27